Loading…

CHEK2 1100delC mutation is frequent among Russian breast cancer patients

This study was aimed to assess the role of CHEK2 1100delC mutation in breast cancer (BC) predisposition in Russia. The 1100delC allele was detected in 14/660 (2.1%) unilateral BC cases and in 8/155 (5.2%) patients with the bilateral form of the disease, but only in 1/448 (0.2%) middle-aged control f...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research and treatment 2006-11, Vol.100 (1), p.99-102
Main Authors: Chekmariova, Elena V, Sokolenko, Anna P, Buslov, Konstantin G, Iyevleva, Aglaya G, Ulibina, Yulia M, Rozanov, Maxim E, Mitiushkina, Natalia V, Togo, Alexandr V, Matsko, Dmitry E, Voskresenskiy, Dmitry A, Chagunava, Oleg L, Devilee, Peter, Cornelisse, Cees, Semiglazov, Vladimir F, Imyanitov, Evgeny N
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study was aimed to assess the role of CHEK2 1100delC mutation in breast cancer (BC) predisposition in Russia. The 1100delC allele was detected in 14/660 (2.1%) unilateral BC cases and in 8/155 (5.2%) patients with the bilateral form of the disease, but only in 1/448 (0.2%) middle-aged control females and in none of 373 elderly tumor-free women. The obtained data point at potentially high clinical relevance of CHEK2 1100delC testing in females of Russian origin and warrant similar case-control studies in ethnically and geographically related regions, especially in Ukraine, Belarus and Baltic countries.
ISSN:0167-6806
1573-7217
DOI:10.1007/s10549-006-9227-7